Next 10 |
HAYWARD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
2024-04-27 14:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
2024-04-18 12:42:59 ET More on Mid-day movers & stocks. Canopy Growth Is Climbing, But It Won't Last Canopy Growth Corporation (CGC) Q3 2024 Earnings Call Transcript Canopy Growth: Reiterate Strong Sell, Dilutive Offering Likely First Of Many To Come Cano...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 08:55:05 ET More on Benitec Netflix, Johnson & Johnson, Procter & Gamble And Baidu On Watch Benitec Biopharma jumps 33% on $40M private financing Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Fi...
2024-04-18 08:06:51 ET DENVER, Colo., Apr 18, 2024 ( 247marketnews.com )- Benitec Biopharma Inc. (NASDAQ: BNTC ) reported positive interim clinical data and a private investment from the sale of 5,749,152 shares of its common stock at a price per share of $4.80 and 2,584,239 pre-fun...
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements across multiple measures of swallowing function in the first Phase 1b/2a clinical study subje...
2024-04-18 07:14:34 ET More on Benitec Netflix, Johnson & Johnson, Procter & Gamble And Baidu On Watch Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Read the full article on Seeking Alpha For further detai...
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
HAYWARD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
2024-04-27 14:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Thursday, Benitec Biopharma Inc (NASDAQ:BNTC) released interim clinical data from the 90-day timepoint following the administration of BB...